AstraZeneca seeks to calm CEO speculation after shares drop

AstraZeneca (AZN.L) appeared to play down speculation about the future of its CEO after its shares fell more than 4% on Monday following a British tabloid report that Pascal Soriot was considering leaving the drugmaker as soon as next year.